Skip to main content
Erschienen in: Journal of Nuclear Cardiology 6/2021

22.07.2020 | Editorial

Narrowing in on a PET tracer that characterizes coronary atheroma: 18F-NaF uptake is increased in stenotic coronary artery disease

verfasst von: Michael T. Osborne, MD, Taimur A. Abbasi, MD, Mazen S. Albaghdadi, MD, Msc

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Excerpt

A positron emission tomography (PET) imaging tracer that provides a meaningful and clinically deployable risk assessment in coronary artery disease (CAD) has been sought enthusiastically for over a decade. Molecular imaging with PET is uniquely suited for imaging atherosclerosis because it is performed in conjunction with computed tomography (CT) or magnetic resonance imaging as part of a single scan, allowing a simultaneous assessment of disease pathobiology and activity at a molecular level as well as an anatomic evaluation of atherosclerotic plaques. While PET imaging has established itself as a mainstay for the functional assessment of CAD physiology, PET has not yet met its great potential to deliver a measurement of biological activity in coronary atheroma that concurrently provides meaningful clinical risk stratification. …
Literatur
1.
Zurück zum Zitat Joseph P, Tawakol A (2016) Imaging atherosclerosis with positron emission tomography. Eur Heart J 37:2974-2980CrossRef Joseph P, Tawakol A (2016) Imaging atherosclerosis with positron emission tomography. Eur Heart J 37:2974-2980CrossRef
2.
Zurück zum Zitat Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA et al (2010) Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 3:388-397CrossRef Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA et al (2010) Feasibility of FDG imaging of the coronary arteries: Comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 3:388-397CrossRef
3.
Zurück zum Zitat Chowdhury MM, Tarkin JM, Albaghdadi MS, Evans NR, Le EPV, Berrett TB et al (2020) Vascular positron emission tomography and restenosis in symptomatic peripheral arterial disease: A prospective clinical study. JACC Cardiovasc Imaging 13:1008-1017CrossRef Chowdhury MM, Tarkin JM, Albaghdadi MS, Evans NR, Le EPV, Berrett TB et al (2020) Vascular positron emission tomography and restenosis in symptomatic peripheral arterial disease: A prospective clinical study. JACC Cardiovasc Imaging 13:1008-1017CrossRef
4.
Zurück zum Zitat Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS et al (2014) 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 7:371-378CrossRef Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS et al (2014) 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 7:371-378CrossRef
5.
Zurück zum Zitat Joshi NV, Vesey AT, Williams MC, Shah ASV, Calvert PA, Craighead FHM et al (2014) 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 383:705-713CrossRef Joshi NV, Vesey AT, Williams MC, Shah ASV, Calvert PA, Craighead FHM et al (2014) 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 383:705-713CrossRef
6.
Zurück zum Zitat Vesey AT, Jenkins W, Forsythe R, Rudd JH, Sng G, Fletcher AM et al (2017) 18F-Fluoride and 18F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor stroke: Case-control study. Circ Cardiovasc Imaging 10:e004976CrossRef Vesey AT, Jenkins W, Forsythe R, Rudd JH, Sng G, Fletcher AM et al (2017) 18F-Fluoride and 18F-fluorodeoxyglucose positron emission tomography after transient ischemic attack or minor stroke: Case-control study. Circ Cardiovasc Imaging 10:e004976CrossRef
7.
Zurück zum Zitat Kwiecinski J, Tzolos E, Adamson PD, Cadet S, Moss AJ, Joshi N et al (2020) Coronary (18)F-sodium fluoride uptake predicts outcomes in patients with coronary artery disease. J Am Coll Cardiol 75:3061-3074CrossRef Kwiecinski J, Tzolos E, Adamson PD, Cadet S, Moss AJ, Joshi N et al (2020) Coronary (18)F-sodium fluoride uptake predicts outcomes in patients with coronary artery disease. J Am Coll Cardiol 75:3061-3074CrossRef
8.
Zurück zum Zitat Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM et al (2012) Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 59:1539-1548CrossRef Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM et al (2012) Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 59:1539-1548CrossRef
9.
10.
Zurück zum Zitat Delgado V, Saraste A, Dweck M, Bucciarelli-Ducci C, Bax JJ (2020) Multimodality imaging: Bird's eye view from the European Society of Cardiology Congress 2019 Paris, August 31st-September 4th, 2019. J Nucl Cardiol 27:53-61CrossRef Delgado V, Saraste A, Dweck M, Bucciarelli-Ducci C, Bax JJ (2020) Multimodality imaging: Bird's eye view from the European Society of Cardiology Congress 2019 Paris, August 31st-September 4th, 2019. J Nucl Cardiol 27:53-61CrossRef
11.
Zurück zum Zitat Hayrapetian A, Berenji GR, Nguyen KL, Li Y (2020) 18F-sodium fluoride uptake is associated with severity of atherosclerotic stenosis in stable ischemic heart disease. J Nucl Cardiol Hayrapetian A, Berenji GR, Nguyen KL, Li Y (2020) 18F-sodium fluoride uptake is associated with severity of atherosclerotic stenosis in stable ischemic heart disease. J Nucl Cardiol
12.
Zurück zum Zitat Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR et al (2015) Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 65:1273-1282CrossRef Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR et al (2015) Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 65:1273-1282CrossRef
13.
Zurück zum Zitat Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M et al (2004) Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 164:1427-1436CrossRef Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M et al (2004) Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 164:1427-1436CrossRef
14.
Zurück zum Zitat Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV et al (2017) Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging. J Am Coll Cardiol 69:1774-1791CrossRef Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV et al (2017) Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging. J Am Coll Cardiol 69:1774-1791CrossRef
Metadaten
Titel
Narrowing in on a PET tracer that characterizes coronary atheroma: 18F-NaF uptake is increased in stenotic coronary artery disease
verfasst von
Michael T. Osborne, MD
Taimur A. Abbasi, MD
Mazen S. Albaghdadi, MD, Msc
Publikationsdatum
22.07.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 6/2021
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02279-x

Weitere Artikel der Ausgabe 6/2021

Journal of Nuclear Cardiology 6/2021 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.